EXPLORE THE SCIENCE
TL;DR: A 2026 study in Biological Psychiatry: Global Open Science linked serious physical injury to recurrent major depression and found that injury-related DNA methylation patterns differed by depression status, with oxytocin, GABA, and synaptic-plasticity pa…
Read article
Depression Genetics Points to Altered DLPFC Cell Types TL;DR: A Nature Genetics study mapped more than 200,000 cells from the dorsolateral prefrontal cortex and found depression-linked regulatory changes concentrated in deep-layer excitatory neurons and a micr…
Read article
Elevated fingernail cortisol levels can distinguish individuals with lifetime major depressive disorder (MDD) from healthy controls, suggesting it as a promising biomarker for MDD. Highlights: Individuals with lifetime MDD had significantly higher fingernail c…
Read article
Probiotic treatment may influence core clock gene expression and metabolites in individuals with major depressive disorder (MDD), potentially linking gut microbiota to circadian rhythms and mood regulation. Highlights: CLOCK Gene Expression: The expression lev…
Read article
Transcranial direct current stimulation (tDCS) targeting the left dorsolateral prefrontal cortex (DLPFC) at 2-mA intensity effectively alleviates depressive symptoms and shows promise in reducing anxiety symptoms across various clinical conditions. Highlights:…
Read article
A study found shared brain-specific mechanisms between Alzheimer’s disease (AD) and depression, particularly involving synaptic signaling and immune system pathways in the hippocampus, but no direct genetic overlap. Highlights: Six brain-specific eQTL genes (S…
Read article
Ketamine significantly reduces suicidal ideation in depressed patients, with rapid effects observed within the first day of treatment. Highlights: Rapid Reduction: Ketamine shows a significant reduction in suicidal ideation within the first day of treatment (R…
Read article
Repurposing general anesthetic drugs like ketamine for the treatment of major depression represents a significant medical advancement – showcasing rapid and sustained antidepressant effects. Highlights: Rapid Antidepressant Effects: Ketamine, nitrous oxide, pr…
Read article
The study suggests that microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in blood and brain tissues can serve as significant biomarkers for diagnosing and monitoring major depressive disorder (MDD). Highlights: Diagnostic Potential: miRNAs and lncRNAs sho…
Read article
Transcranial magnetic stimulation (TMS) is underutilized in treating major depressive disorder (MDD) despite showing significant clinical benefits, with barriers including insurance coverage and limited access. Highlights: Study Scope: Analyzed real-world data…
Read article